media – Page 547 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

Mersana’s Lead Cancer ADC Held Up by FDA for Patient’s Death

The FDA held up Mersana’s top antibody-drug conjugate (ADC), XMT-1522 over safety issues following a patient’s death in phase 1 trial, causing a descent in the company’s shares.
- Source: FierceBiotech
- 262
- July 25, 2018
cancer Clinical Trial FDA
Fatty Liver Recovers Speedily After Hepatitis C Cure

A report in Alimentary Pharmacology and Therapeutics revealed that Liver stiffness and liver fat (steatosis) in chronic hepatitis C virus (HCV) infected patients improved considerably post-treatment with direct-acting antivirals (DAAs) resulting in sustained virological response (SVR). A fall in ALT levels and a rise in platelet count was observed six months after SVR.
- Source: WorldHepatitisAlliance
- 1,512
- July 24, 2018
Fatty liver disease hepatitis C Researches
Physiotherapy can Improve QoL of Cerebral Palsy Patients

Cerebral palsy is a neurological disorder diagnosed during early childhood when a child is having problems with posture, gait and muscle tone. Cerebral palsy occurs due to damage of the cerebral portion of the brain that controls muscle tone and movements.
- Source: HealthForU
- 544
- July 24, 2018
cerebral plasy physiotherapy Researches
Children of Type 1 Diabetes Patients at Risk of Obesity

Type 1 diabetes is the most common metabolic disorder observed among children. It is a well-known fact that children who have diabetic parents are at higher risk of developing the disease.
- Source: News Medical
- 693
- July 24, 2018
Researches type 1 diabetes
Karyopharm Seeks FDA Approval for Selinexor Drug for Multiple Myeloma

The Newton Massachusetts-based company, Karyopharm Therapeutics, who developed a new class of drugs to treat multiple myeloma, is in the process of submitting a new drug application to the FDA for their selinexor drug.
- Source: MedCityNews
- 462
- July 24, 2018
cancer CAR-T therapies FDA New Approvals
Invention of Sensor to Monitor High Risk Pregnancies

A research team at the Imperial College London have developed a new sensor-based device to display fetal movements and growth in high-risk pregnancies. This is an alternative to the current self-reporting system where the mothers notice changes in fetus movements and seek medical help if needed.
- Source: The Verdict
- 677
- July 24, 2018
fetus Researches
AbbVie Investors Need not Abandon Ship yet

After watching Scott Gottlieb, M.D. of the FDA comments regarding the rebate rule changes and a warning tweet on biosimilars, AbbVie investors are bailing out. But the industry watchers claim that they don’t need to be.
- Source: FiercePharma
- 1,182
- July 24, 2018
AbbVie biopharmaceutical FDA Market Views
LabCorp won’t Confirm if SamSam is the Ransomware it’s Recovering from

LabCorp, the mammoth medical investigations company, is still recuperating from a major ransomware attack and, almost a week later, won’t reveal how the hackers got entry nor the number of servers that were hit.
- Source: Healthcare IT News
- 877
- July 24, 2018
Company Insight cybersecurity digital health
AI Code of Conduct to be Laid Down by NHS Later in 2018

In the latter part of this year, a code of conduct for the use of artificial intelligence (AI) in healthcare will be introduced by the NHS, England, announced Harpreet Sood, associate CCIO at NHS England, at The King’s Fund’s Digital Health and Care Congress 2018 on 11 July.
- Source: DigitalHealth.net
- 971
- July 24, 2018
AI NHS Policies
Survival Rates After HCV-related Liver Transplant Rise on Administration of DAAs

Investigators from Catalonia reported in the Journal of Hepatology that survival rate among hepatitis C virus (HCV) positive patients undertaking liver transplant have significantly risen after the administration of direct-acting antivirals (DAAs). DAAs also lead to a fall in the number of people with HCV requiring a liver transplant.
- Source: WorldHepatitisAlliance
- 727
- July 23, 2018
hepatitis liver transplantation Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.